Cargando…
Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients
BACKGROUND: β-blockers may protect against catecholaminergic myocardial injury in critically ill patients. Long-term β-blocker users are known to have lower lactate concentrations and favorable sepsis outcomes. However, the effects of β1-selective and nonselective β-blockers on sepsis outcomes have...
Autores principales: | Kuo, Ming-Jen, Chou, Ruey-Hsing, Lu, Ya-Wen, Guo, Jiun-Yu, Tsai, Yi-Lin, Wu, Cheng-Hsueh, Huang, Po-Hsun, Lin, Shing-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116825/ https://www.ncbi.nlm.nih.gov/pubmed/33985572 http://dx.doi.org/10.1186/s40560-021-00553-9 |
Ejemplares similares
-
Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients
por: Chou, Ruey-Hsing, et al.
Publicado: (2021) -
Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies
por: Hong, Shiao-Ya, et al.
Publicado: (2023) -
Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography
por: Kuo, Chin-Sung, et al.
Publicado: (2020) -
Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014) -
β-blockers in septic shock: are we there yet?
por: Cruz, Madalena Coutinho, et al.
Publicado: (2017)